Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,404,663
-$182,180 QoQ
Shares Held
3,879
-14.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,478
of 3,149 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATURAL INVESTMENTS, LLC holds $27,100,287 across 13 Drug Manufacturers - General names. AMGN ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
33,331 | $8,387,412 | |
| 2 | LLY |
ELI LILLY & Co
|
5,609 | $6,727,603 | |
| 3 | AZN |
Astrazeneca PLC
|
13,360 | $2,533,323 | |
| 4 | JNJ |
Johnson & Johnson
|
9,613 | $2,441,413 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,454 | $1,985,839 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,879 | $1,404,663 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,354 | $929,104 | |
| 8 | NVS |
Novartis AG
|
5,116 | $801,779 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,404,663 | 3,879 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,586,843 | 4,510 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,429,035 | 4,366 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,067,844 | 3,784 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,047,595 | 3,752 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,475,812 | 4,737 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,248,726 | 4,791 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||